Who owns MEI PHARMA INC?
- Ticker: LITS
- CUSIP Number: 55279b301
Tip: Access positions for across all investors
Analyze quarterly positions in Mei Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Mei Pharma stock
Who bought or sold MEI PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Renaissance Technologies | 1.2M | $1.2M | -29% | Jun 2026 |
|
| Vanguard Capital Management | 1.0M | $942k | -2% | Jun 2026 |
|
| Citadel Advisors | 990k | $913k | 29% | Jun 2026 |
|
| RLH Capital | 806k | $744k | 100% | Jun 2026 |
|
| Two Sigma Investments | 557k | $514k | -9% | Jun 2026 |
|
| Geode Capital Management | 365k | $337k | -9% | Jun 2026 |
|
| BlackRock | 276k | $254k | 75% | Jun 2026 |
|
| Marshall Wace | 233k | $214k | -30% | Jun 2026 |
|
| Jane Street | 224k | $206k | 179% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 195k | $180k | 1% | Jun 2026 |
|
| State Street Corporation | 115k | $133k | 0% | Mar 2026 |
|
| UBS Group | 91k | $85k | 77% | Jun 2026 |
|
| Northern Trust | 76k | $70k | -6% | Jun 2026 |
|
| Morgan Stanley | 71k | $83k | 0% | Mar 2026 |
|
| XTX Topco | 68k | $63k | -50% | Jun 2026 |
|
| ADAR1 Capital Management | 67k | $62k | 0% | Jun 2026 |
|
| GSA Capital Partners | 62k | $57k | 100% | Jun 2026 |
|
| Susquehanna International | 37k | $34k | 34% | Jun 2026 |
|
| Nomura Asset Management International | 30k | $28k | 0% | Jun 2026 |
|
| Clear Street Group | 25k | $23k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 18k | $17k | 0% | Jun 2026 |
|
| Two Sigma Securities | 14k | $13k | 100% | Jun 2026 |
|
| Group One Trading | 2.6k | $2.4k | -89% | Jun 2026 |
|
| Newbridge Financial Services Group | 2.0k | $1.8k | 0% | Jun 2026 |
|
| Barclays | 532.00 | $490.982800 | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 462.00 | $426.010200 | 0% | Jun 2026 |
|
| HighMark Wealth Management | 287.00 | $264.011300 | 0% | Jun 2026 |
|
| Evermay Wealth Management | 126.00 | $117.003600 | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 67.00 | $60.460800 | 100% | Jun 2026 |
|
| Wells Fargo & Company | 25.00 | $23.000000 | 0% | Jun 2026 |
|
| Larson Financial Group | 8.00 | $7.000000 | 0% | Jun 2026 |
|
| Farther Finance Advisors | 2.00 | $2.000000 | 0% | Jun 2026 |
|
| Advisor Group Holdings | 2.00 | $0 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 1.00 | $1.000000 | -75% | Jun 2026 |
|
| International Assets Investment Management | 1.00 | $1.000000 | 0% | Jun 2026 |
|
| SBI Securities | 1.00 | $1.000000 | 0% | Jun 2026 |
|
| Citigroup | 1.00 | $1.000000 | 100% | Mar 2026 |
|
| CWM | 1.00 | $1.000000 | 0% | Mar 2026 |
|
Who sold out of Mei Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bank Julius Baer & Co. Ltd, Zurich | Mar 2026 | 2.2k | $2.5k |
| MAI Wealth Advisors | Mar 2026 | 75.00 | $87.000000 |
| FMR | Mar 2026 | 3.00 | $3.000000 |